(Z)-9-Octadecenoic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000089
Compound index — Z
125 substances begin with Z. 1 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 125 of them, (Z)-9-Octadecenoic acid – Zuranolone.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
(Z)-Ixabepilone US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-000111
(Z,Z,)-9,12-Octadecadienoic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000088
(z,z,z) octadeca-6, 9, 12 trienoic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-010385
(Z,Z,Z)-9,12,15-Octadecatrienoic acid CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-000087
Zadavotide Guraxetan US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015559
Zafirlukast US-DRUG Not yet graded
US: anda
Class as recordedCytochrome P450 2C9 Inhibitors [MoA]; Leukotriene Receptor Antagonist [EPC]; Leukotriene Receptor Antagonists [MoA]
Earliest US approval1996
Market presence20 US product listings · 5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015560
Zaire Ebolavirus (strain Kikwit-95) Envelope Glycoprotein US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015561
Zalcitabine US-DRUG Not yet graded
Earliest US approval1992
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015562
Zaleplon EU-MEDUS-CSAUS-DRUG Not yet graded
CSA Schedule IVEU medicine: WithdrawnUS: anda
Class as recordedCentral Nervous System Depression [PE]; DEA: depressant; GABA A Agonists [MoA]; N05CF03
Earliest US approval1999
Market presence27 US product listings · 11 FDA applications · 2 EU medicines
DEA other namesSonata
Etalyn identifierETA-C-015571
Zanamivir EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedJ05AH01; Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]
Earliest US approval1999
Market presence3 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-015564
Zanidatamab-Hrii US-DRUG Not yet graded
Earliest US approval2024
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015566
Zantedeschia Aethiopica Flower US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015567
Zanthoxylum americanum CA-NHP Not yet graded
CA licensed ingredient
Market presence24 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015568
Zanthoxylum Americanum Bark US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence41 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015569
Zanthoxylum bungeanum CA-NHP Not yet graded
CA licensed ingredient
Market presence95 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015570
Zanthoxylum Bungeanum Fruit US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015571
Zanthoxylum Bungeanum Fruit Extract CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015572
Zanthoxylum clava-herculis CA-NHP Not yet graded
CA licensed ingredient
Market presence24 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015573
Zanthoxylum nitidum CA-NHP Not yet graded
CA licensed ingredient
Market presence25 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015574
Zanthoxylum piperitum EU-NOVEL Not yet graded
Not novel in food
Parts in scopeFruits
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-015575
Zanthoxylum schinifolium CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015576
Zanubrutinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBruton's Tyrosine Kinase Inhibitors [MoA]; Kinase Inhibitor [EPC]; L01EL03
Earliest US approval2019
Market presence15 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-015577
Zaocys dhumnades CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015578
Zasocitinib US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015579
Zataria multiflora CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015580
Zavegepant Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Class as recordedCalcitonin Gene-related Peptide Receptor Antagonist [EPC]; Calcitonin Gene-related Peptide Receptor Antagonists [MoA]
Earliest US approval2023
Market presence9 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015581
Zea mays CA-NHPEU-CLAIMEU-NOVEL Not yet graded
Not novel in foodEU claims 0 authorised / 3 refusedCA licensed ingredient
also: Mays vulgaris Ser., Mayzea vestita Raf., Zea alba Mill.
Market presence359 Canadian licensed products
Parts in scopeGrain, seed (kernel) and seed oil; Non-concentrated aqueous infusion from styles; Flower and rootlets of germinated seed
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “For the urogenital system health '— kidney activity improving, lightly diuretic, disinfecting and anti-inflammatory effect” | Non-authorised | Art.13(1) | EFSA opinion |
| “For the urogenital system health '— kidney activity improving, lightly diuretic, disinfecting and anti-inflammatory effect” | Non-authorised | Art.13(1) | EFSA opinion |
| “For liver and gallbladder health — beneficially affects the function of liver and gallbladder 2. A beneficial effect in case of acute condition of chronic pancreatitis 3. Beneficially affects digestion and promotes body's detoxification processes” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015583
Zea mays L. ; Common name : Maïs EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Facilite la perte de poids en complément de mesures diététiques. Help weight loss in addition to dieting” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015584
ZEA Mays Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence36 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015585
ZEA Mays Subsp. Mays Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015586
Zea maïs CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015582
Zeaxanthin CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 0 authorised / 1 refusedCA licensed ingredientUS: unapproved homeopathic
Class as recordedAntimalarial [EPC]
Market presence1 US product listings · 32 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “An optimal intake of zeaxanthin contributes to eye health supports normal vision absorbs blue light and scavenges reactive oxygen species in the eye (lens, retina) and, therefore, helps to maintain a healthy retina stabilizes membranes and, therefore, contributes to make retinal membranes more resistant against damage by light (together with Lutein) is actively accumulated in the healthy macula. The highest…” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015587
Zeaxanthin ( from marigold/ capsicum extract / wolfberries fruit. EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps support eye health helps maintain healthy eyes nutrition for eye promotes healthy eye function helps maintain macular and retinal health is one(of the) constituent(s) of the retina and the lens/is deposited naturally in the eye is a constituent of the macular pigment is highly and selectively accumulated in the retina is highly and selectively accumulated in the macula lutea contributes to macular…” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015589
Zeaxanthin esters CA-NHP Not yet graded
CA licensed ingredient
Market presence40 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015588
zeaxantin EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “helps to maintain normal vision, recomended in dry and irritable eyes, incineration and ephiphora and inflamed eyelids, helps to preserve elasticity and permeability of capilars of retina and supports good blood circulation in eyes” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015590
Zelnecirnon US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015591
Zeltnera Venusta Whole Flowering US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015592
Zenocutuzumab US-DRUG Not yet graded
US: bla
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015593
Zenocutuzumab-Zbco US-DRUG Not yet graded
Earliest US approval2024
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015594
Zeolite - clinoptilolit EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Might help to protect the body tissues and cells from oxidative damage, viruses, heavy metals, toxines and free radicals, alergenes and radionuclids. Might helps to keep normal level of blood cholesterol, lipid and sugar. Might be useful in increasing the bioavailability of vitamins, minerals and nutritive substances from food. Balances the pH level of organism and it might rejuvenate the intestine peristaltic.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015596
Zeranol US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015597
Zhi Qiao CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015598
Zibotentan US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015599
Ziconotide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedN-Calcium Channel Receptor Antagonists [MoA]; N-type Calcium Channel Antagonist [EPC]; N02BG08
Earliest US approval2004
Market presence8 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-015600
Zidebactam US-DRUG Not yet graded
US: nda
Class as recordedCephalosporin Antibacterial [EPC]; Cephalosporins [CS]
Earliest US approval2026
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015601
Zidesamtinib US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2026
Market presence5 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015602
Zidovudine EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedCytochrome P450 1A1 Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; J05AR01
Earliest US approval1987
Market presence33 US product listings · 59 FDA applications · 3 EU medicines
Etalyn identifierETA-C-015603
Ziftomenib US-DRUG Not yet graded
US: drug for further processing
Earliest US approval2025
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015604
Zileuton US-DRUG Not yet graded
US: anda
Class as recorded5-Lipoxygenase Inhibitor [EPC]; 5-Lipoxygenase Inhibitors [MoA]; Decreased Leukotriene Production [PE]
Earliest US approval1996
Market presence14 US product listings · 8 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015605
Zilpaterol Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015606
Zilucoplan EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedComplement Inhibitor [EPC]; Complement Inhibitors [MoA]; L04AJ06
Earliest US approval2023
Market presence5 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-015607
Zinc CA-NHPETALYNEU-CLAIMEU-MEDUS-DRUG D/contestedband 4
EU medicine: AuthorisedEU claims 18 authorised / 7 refusedCA licensed ingredientUS: anda
Class as recordedA16AX05; Acetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Acidifying Activity [MoA]
Earliest US approval1986
Market presence690 US product listings · 17 FDA applications · 1 EU medicines · 13,730 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s. 12 of 25 shown.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Prevents bad breath by neutralising of volatile sulphur compounds (VSC) in the mouth and oral cavity.” | Non-authorised | Art.13(5) | EFSA opinion |
| “Zinc contributes to the protection of cells from oxidative stress” | Authorised | Art.13(1) | EFSA opinion |
| “Zinc has a role in the process of cell division” | Authorised | Art.13(1) | EFSA opinion |
| “Zinc contributes to normal DNA synthesis” | Authorised | Art.13(1) | EFSA opinion |
| “Zinc contributes to normal acid-base metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Zinc contributes to normal carbohydrate metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Zinc contributes to normal cognitive function” | Authorised | Art.13(1) | EFSA opinion |
| “Zinc contributes to normal fertility and reproduction” | Authorised | Art.13(1) | EFSA opinion |
| “Zinc contributes to normal macronutrient metabolism” | Authorised | Art.13(1) | EFSA opinion |
| “Zinc contributes to normal metabolism of fatty acids” | Authorised | Art.13(1) | EFSA opinion |
| “Zinc contributes to normal metabolism of vitamin A” | Authorised | Art.13(1) | EFSA opinion |
| “Zinc contributes to normal protein synthesis” | Authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015608
Zinc Ascorbate US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAcidifying Activity [MoA]; Anti-coagulant [EPC]; Ascorbic Acid [CS]; Calcium Chelating Activity [MoA]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015609
Zinc Bisglycinate CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015610
Zinc Carbobenzoxy-.beta.-Alanyltaurinate US-DRUG Not yet graded
US: unapproved homeopathic
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015611
Zinc carnosine EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Gastric comfort. Supports a healthy gastric environment. Zinc-carnosine supports the natural defenses and healthy ecology of the gastric lining.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015612
Zinc Cation US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015613
Zinc Glycinate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015614
Zinc Monoethylfumarate US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015615
Zinc Oxide CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: bulk ingredient
Class as recordedAcidifying Activity [MoA]; Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]; Adrenergic alpha1-Agonists [MoA]
Earliest US approval2006
Market presence5,011 US product listings · 1 FDA applications · 2,122 Canadian licensed products
Etalyn identifierETA-C-015616
Zinc PCA US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015617
Zinc Phosphide US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCalculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015618
Zinc Picolinate US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015619
Zinc Picrate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedIncreased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015620
Zinc Picrate Nonahydrate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCopper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015621
Zinc Pyrithione US-DRUG Not yet graded
US: bulk ingredient for human prescription compounding
Market presence11 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015622
Zinc Sulfate Heptahydrate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]
Market presence27 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015623
Zinc Sulfate Heptahydrate, Cupric Sulfate, Manganese Sulfate, Selenious Acid US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015624
Zinc Sulfate Monohydrate Micronized CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015625
Zinc Sulfate, Unspecified Form US-DRUG Not yet graded
US: anda
Class as recordedAnalogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Calculi Dissolution Agent [EPC]; Copper Absorption Inhibitor [EPC]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015626
Zinc Undecylenate US-DRUG Not yet graded
US: bulk ingredient
Market presence14 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015627
Zincum aceticum CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015628
Zincum bromatum CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015629
Zincum carbonicum CA-NHP Not yet graded
CA licensed ingredient
Market presence13 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015630
Zincum cyanatum CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015631
Zincum gluconicum CA-NHP Not yet graded
CA licensed ingredient
Market presence18 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015632
Zincum iodatum CA-NHP Not yet graded
CA licensed ingredient
Market presence14 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015633
Zincum isovalerianicum CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015634
Zincum metallicum CA-NHP Not yet graded
CA licensed ingredient
Market presence129 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015635
Zincum muriaticum CA-NHP Not yet graded
CA licensed ingredient
Market presence19 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015636
Zincum oxydatum CA-NHP Not yet graded
CA licensed ingredient
Market presence19 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015637
Zincum phophoratum CA-NHP Not yet graded
CA licensed ingredient
Market presence12 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015638
Zincum phosphoratum CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015639
Zincum phosphoricum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015640
Zincum picricum CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015641
Zincum sulphuricum CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015642
Zincum valerianicum CA-NHP Not yet graded
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015643
Zincum valerianicum CA-NHP Not yet graded
CA licensed ingredient
Market presence23 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015651
Zingiber CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015644
Zingiber officinale CA-NHP Not yet graded
CA licensed ingredient
Market presence5,595 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015645
Zingiber Officinale (ginger) Root Oil US-DRUG Not yet graded
US: otc monograph drug
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015646
Zingiber Officinale Whole US-DRUG Not yet graded
US: drug for further processing
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015647
Zingiberis rhizoma CA-NHPEU-HERBUS-DRUG Not yet graded
Herbal monograph: F: Assessment finalisedCA licensed ingredientUS: bla
also: Ginger; Zingiber officinaleRoscoe
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence108 US product listings · 4 Canadian licensed products
Etalyn identifierETA-C-015648
Zinnia Elegans Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Antimalarial [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015649
Zipalertinib US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015650
Zipeprol (1-methoxy-3[-4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol) US-CSA Not yet graded
CSA Schedule Inarcotic
also: Zipeprol piperazin-1-yl]-1-phenylpropan-2-ol)
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-015651
Ziprasidone US-DRUG Not yet graded
US: anda
Class as recordedAtypical Antipsychotic [EPC]
Earliest US approval2001
Market presence114 US product listings · 15 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015652
Zirconium US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Calcium [CS]; Calcium [EPC]; Cell-mediated Immunity [PE]
Market presence51 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015653
Zirconium Fluoride US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015654
Zirconium Oxide US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015655
ZIV-Aflibercept US-DRUG Not yet graded
Earliest US approval2012
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015656
Zizania aquatica EU-NOVEL Not yet graded
Not novel in food
also: Wild rice
Parts in scopeGrain
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-015657
Zizania palustris EU-NOVEL Not yet graded
Not novel in food
also: Wildrice
Parts in scopeGrain
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-015658
Zizia Aurea Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015659
Ziziphus jujuba var. spinosa CA-NHP Not yet graded
CA licensed ingredient
Market presence330 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015661
Ziziphus mauritiana CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015662
Ziziphus spinosa CA-NHP Not yet graded
CA licensed ingredient
Market presence14 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015663
Ziziphus vulgaris EU-NOVEL Not yet graded
Not novel in food
Parts in scopeFruit
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-015664
Ziziphus zizyphus EU-NOVEL Not yet graded
Not novel in food
Parts in scopeFruit
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-015665
Zolbetuximab EU-MEDUS-DRUG Not yet graded
Zolbetuximab-Clzb US-DRUG Not yet graded
Earliest US approval2024
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015667
Zoledronic Acid EU-MEDUS-DRUG Not yet graded
Zoliflodacin US-DRUG Not yet graded
US: export only
Earliest US approval2025
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015669
Zolmitriptan US-DRUG Not yet graded
US: anda
Class as recordedSerotonin 1b Receptor Agonists [MoA]; Serotonin 1d Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
Earliest US approval1997
Market presence58 US product listings · 26 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015670
Zolpidem US-CSAUS-DRUG Not yet graded
CSA Schedule IVUS: anda
Class as recordedCentral Nervous System Depression [PE]; DEA: depressant; GABA A Agonists [MoA]; GABA A Receptor Positive Modulators [MoA]
Earliest US approval1992
Market presence159 US product listings · 43 FDA applications
DEA other namesAmbien; Ivadal; Stilnoct; Stilnox
Etalyn identifierETA-C-015671
Zongertinib US-DRUG Not yet graded
US: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; HER2/Neu/cerbB2 Antagonists [MoA]; Kinase Inhibitor [EPC]
Earliest US approval2025
Market presence6 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015672
Zonisamide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAnti-epileptic Agent [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; N03AX15
Earliest US approval2000
Market presence75 US product listings · 21 FDA applications · 2 EU medicines
Etalyn identifierETA-C-015673
Zopapogene Imadenovec US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015674
Zotarolimus US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015676
Zucchini US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015677
Zuranolone EU-MEDUS-CSAUS-DRUG Not yet graded
CSA Schedule IVEU medicine: AuthorisedUS: bulk ingredient
Class as recordedDEA: depressant; GABA A Receptor Positive Modulators [MoA]; N06A; Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]
Earliest US approval2023
Market presence8 US product listings · 1 FDA applications · 1 EU medicines
DEA other namesZURZUVAE
Etalyn identifierETA-C-015678